Europe (WHO region) vs Guyana: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Europe (WHO region)
83.0%
in 2025
Guyana
99.0%
in 2025
Europe (WHO region) rank
3rd
Guyana rank
1st
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Europe (WHO region)
- Guyana
How they compare
Guyana currently reports 99.0% against 83.0% in Europe (WHO region), a difference of 16.0%.
That makes Guyana's figure about 1.2 times Europe (WHO region)'s.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Europe (WHO region) ahead.
Europe (WHO region) ranks 3rd and Guyana ranks 1st of 11 groups.
Across the 3 decades both report, Europe (WHO region) averaged higher in 1 and Guyana in 2.
Head to head by decade
| Decade | Europe (WHO region) | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.5% | 0.0% | 15.5% | Europe (WHO region) |
| 2010s | 54.4% | 80.5% | 26.1% | Guyana |
| 2020s | 81.8% | 96.2% | 14.3% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Europe (WHO region) or Guyana?
- Guyana, at 99.0% against 83.0% in Europe (WHO region) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Europe (WHO region) and Guyana?
- 16.0%, with Guyana ahead.
- How many years of comparable data are there for Europe (WHO region) and Guyana?
- 18 years are reported by both, from 2008 to 2025.
- How do Europe (WHO region) and Guyana rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Europe (WHO region) ranks 3rd and Guyana ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.